AR-12 Exhibits Direct and Host-Targeted Antibacterial Activity toward Mycobacterium abscessus
Open Access
- 22 July 2020
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 64 (8)
Abstract
Therapeutic options for Mycobacterium abscessus infections are extremely limited. New or repurposed drugs are needed. The anti- M. abscessus activity of AR-12 (OSU-03012), reported to express broad-spectrum antimicrobial effects, was investigated in vitro and in vivo . Antimicrobial susceptibility testing was performed on 194 clinical isolates. Minimum bactericidal concentration and time-kill kinetics assays were conducted to distinguish the bactericidal versus bacteriostatic activity of AR-12.Keywords
Funding Information
- Natural Science Foundation of Shanghai Municipal Science and Technology Commission (19ZR1442800)
- Medical Guide Program of Shanghai Science and Technology Committee (18411970600)
- Medical Guide Program of Shanghai Science and Technology Committee (19411969600)
- New Frontier Technology Joint Project of Municipal Hospital, Shanghai Shenkang Hospital Development Center (SHDC12017113)
- Shanghai Municipal Health Committee Excellent Talents Training Program (2018YQ55)
- General Project of Shanghai Municipal Health Committee (201940229)
- Project of Top Clinical Medicine Centers and Key Disciplines Construction in Shanghai (2017ZZ02012)
- Natural Science Foundation of Shanghai Municipal Science and Technology Commission (18ZR1431600)
- National Natural Science Foundation of China (81672063, 81971973)
- National Natural Science Foundation of China (81800003)
This publication has 36 references indexed in Scilit:
- Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat Mycobacterium abscessus Pulmonary DiseaseFrontiers in Microbiology, 2019
- Non-tuberculous mycobacterial pulmonary diseaseEuropean Respiratory Journal, 2019
- Mycobacterium abscessuspulmonary disease: individual patient data meta-analysisEuropean Respiratory Journal, 2019
- Mycobacterium abscessus and Antibiotic Resistance: Same As It Ever WasClinical Infectious Diseases, 2019
- Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic FibrosisMicrobial Drug Resistance, 2018
- The celecoxib derivatives AR-12 and AR-14 induce autophagy and clear prion-infected cells from prionsScientific Reports, 2017
- British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)Thorax, 2017
- Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacteriumScience, 2016
- Mycobacterium abscessus: a new antibiotic nightmareJournal of Antimicrobial Chemotherapy, 2012
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007